Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D015774:Ganciclovir / Q000008:administration & dosage* / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009503:Neutropenia / Q000517:prevention & control; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D055502:Secondary Prevention; D035781:Siblings; D014184:Transplantation, Homologous; D014766:Viremia / Q000517:prevention & control
D000998:Antiviral Agents; D015774:Ganciclovir